A 50-year legacy of innovation and a continued commitment to Science. Results. Trust. MARLBOROUGH, MASS., Jan. 25, 2021 Candela, a leading global medical aesthetic device company, today announced the availability of
30 pre-qualified patients will receive treatment with the Vbeam Pulsed Dye Laser to commence the E.V.A. clinic’s-Vascular Birthmarks Foundation’s International Congress on Vascular Anomalies in Athens, Greece, June 7-8, 2019
WAYLAND, Mass. and LAKE FOREST, Calif., March 20, 2019 /PRNewswire/ -- Syneron Medical Ltd. and Candela Corporation (collectively, "Candela"), a leading global aesthetic device company and the exclusive licensee of
JAMA-Dermatology publishes Dr. Roy Geronemus' authored largest study of infants and babies receiving a non-invasive treatment (vs. surgery) for birthmarks, port wine stains and other vascular related skin conditions on
Candela Unveils New Corporate Identity at the 2019 American Academy of Dermatology (AAD) Annual Meeting New brand reflects commitment to Science, Results, Trust WAYLAND, MASSACHUSETTS, March 1, 2019 – Syneron-Candela
Over 30 pre-qualified patients will receive treatment with the Vbeam Pulsed Dye Laser to commence the Vascular Birthmarks Foundation's 18th Annual Conference. WAYLAND, Mass., Sept. 26, 2018 /PRNewswire/ -- Candela
Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Candela’s portfolio, further strengthening their position in multi-application, multi-technology devices WAYLAND, MASSACHUSETTS, September 5, 2018 – Candela Corporation
NOT ALL PRODUCTS AND INDICATIONS ARE LICENSED IN YOUR COUNTRY, PLEASE CHECK WITH YOUR LOCAL REPRESENTATIVE. All personal data submitted to Candela via this website will be held in accordance with our Privacy Notice, which can be viewed here.